Casey Kraning Ph.D

Featured in: Favicon

Articles

Biologics and Biosimilars Landscape: IP, Policy, and Market Developments | JD Supra

Apr 8, 2024 | jdsupra.com | Philip Chen |Andria Rae Crisler |Casey Kraning Ph.D

In this review, we discuss the most important recent developments in the biosimilars space, including new biosimilar approvals and launches, litigation under the Biologics Price Competition and Innovation Act (BPCIA), post-grant disputes on biologic drug patents before the United States Patent and Trademark Office (USPTO), and proposed legislation and regulatory activities relating to biosimilars.

Try JournoFinder For Free

Search and contact over 1M+ journalist profiles, browse 100M+ articles, and unlock powerful PR tools.